Logo of nihpaLink to Publisher's site
PMC full text:
Trends Cardiovasc Med. Author manuscript; available in PMC 2013 Aug 29.
Published in final edited form as:
Trends Cardiovasc Med. 2012 May; 22(4): 98–105.
Published online 2012 Aug 29. doi: 10.1016/j.tcm.2012.07.003

Table 2

Characteristics of Loss-of-Function Models for PGC-1 Proteins in Response to Pressure Overload

Knockout ModelsPGC-1α-KOPGC-1β-KO
Parameter
Heart size=
Fibrosis= / ↑
Contractile performance and capacity
 Echocardiography
 LV Cath
 Cardiac output (IWH)ND= (3 wk post TAC)
 Cardiac power (IWH)ND= (3 wk post TAC)
Mitochondrial volume densityND=
Mitochondrial function / Energetic reserves
 VADPND= Pyr, ↓ PC
 ATP-synthesisND= Pyr, ↓ PC
 ATP/OND= Pyr, = PC
↓ succinate dehydrogenase / cytochrome oxidase (in situ activity stains)
↓ Citrate synthase
Substrate metabolism
 Glucose oxidationND↓ (3 wk post TAC)
 GlycolysisND↓ (3 wk post TAC)
 Palmitate oxidationND= (3 wk post TAC)
FAO gene expression= / ↓=
OXPHOS gene expression= / ↓= / ↓
ANP, BNP expression=
Oxidative stress
ReferencesArany et al. 2006; Lu et al. 2010Riehle et al. 2011

ND, not determined. FAO, fatty acid oxidation; IWH, isolated working heart preparations; LV Cath, left ventricular catheterization; OXPHOS, oxidative phosphorylation; VADP, maximal mitochondrial oxygen consumption following incubation of saponin permeabilized cardiac fibers to ADP with pyruvate (Pyr) or palmitoyl-L-carnitine (PC) as substrate respectively, each combined with malate. Characteristics for PGC-1β-KO mice are presented vs. TAC operated WT controls 8 weeks post TAC unless otherwise indicated. No gain-of-function models for PGC-1 proteins in response to pressure overload have been described yet. No transgenic mouse model with modulated PRC expression in the heart has been yet reported.

-